{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:24:52Z","timestamp":1790868292017,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1980,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/jto.0b013e3181dc211f","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T09:42:07Z","timestamp":1275039727000},"page":"940-949","source":"Crossref","is-referenced-by-count":71,"title":["Treatment with HIF-1\u03b1 Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice"],"prefix":"10.1016","volume":"5","author":[{"given":"J\u00f6rg J.","family":"Jacoby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Erez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Korshunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Lippman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Powis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy S.","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181dc211f_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib2","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1200\/JCO.2005.02.840","article-title":"TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.drudis.2007.08.006","article-title":"Evaluation of HIF-1 inhibitors as anticancer agents","volume":"12","author":"Semenza","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tibs.2008.08.002","article-title":"HIF-1 regulation: not so easy come, easy go","volume":"33","author":"Yee Koh","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0076-6879(07)35016-7","article-title":"HIF gene expression in cancer therapy","volume":"435","author":"Chan","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","article-title":"Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival","volume":"85","author":"Giatromanolaki","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/path.1330","article-title":"DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer","volume":"200","author":"Giatromanolaki","year":"2003","journal-title":"J Pathol"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ejcts.2006.03.027","article-title":"Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung","volume":"29","author":"Enatsu","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/thx.2009.115691","article-title":"Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer","volume":"64","author":"Hung","year":"2009","journal-title":"Thorax"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00408-009-9169-z","article-title":"Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma","volume":"187","author":"Ioannou","year":"2009","journal-title":"Lung"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib15","unstructured":"Karetsi E, Kerenidi T, Ioannou M, et al. Clinical significance of hypoxia inducible factor-1 alpha and VEGF expression in lung cancer. European Respiratory Society (ERS) Annual Meeting, Vienna, 2009; Abstract 283."},{"key":"10.1097\/JTO.0b013e3181dc211f_bib16","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1200\/JCO.2007.12.0352","article-title":"Three-gene prognostic classifier for early-stage non small-cell lung cancer","volume":"25","author":"Lau","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","article-title":"Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha","volume":"3","author":"Welsh","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib18","first-page":"573","article-title":"Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice","volume":"9","author":"Yano","year":"1997","journal-title":"Oncol Res"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib19","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci US A"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib20","first-page":"5532","article-title":"Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice","volume":"9","author":"Onn","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1535-7163.MCT-06-0416","article-title":"Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade","volume":"6","author":"Wu","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181dc211f_bib22","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/ijc.23807","article-title":"PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells","volume":"123","author":"Palayoor","year":"2008","journal-title":"Int J Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415305360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415305360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:39:39Z","timestamp":1685612379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415305360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1556086415305360"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181dc211f","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}